BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 16899594)

  • 21. High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.
    Antonelli A; Ferri C; Fallahi P; Ferrari SM; Sebastiani M; Ferrari D; Giunti M; Frascerra S; Tolari S; Franzoni F; Galetta F; Marchi S; Ferrannini E
    Am J Gastroenterol; 2008 Oct; 103(10):2488-94. PubMed ID: 18775023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.
    Schupper H; Hayashi P; Scheffel J; Aceituno S; Paglieroni T; Holland PV; Zeldis JB
    Hepatology; 1993 Nov; 18(5):1055-60. PubMed ID: 7693570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.
    Persico M; Capasso M; Persico E; Masarone M; Renzo Ad; Spano D; Bruno S; Iolascon A
    J Hepatol; 2006 Dec; 45(6):779-85. PubMed ID: 17049666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.
    Saadoun D; Bieche I; Authier FJ; Laurendeau I; Jambou F; Piette JC; Vidaud M; Maisonobe T; Cacoub P
    Arthritis Rheum; 2007 Apr; 56(4):1315-24. PubMed ID: 17393409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia.
    Kaplanski G; Maisonobe T; Marin V; Grès S; Robitail S; Farnarier C; Harlé JR; Piette JC; Cacoub P
    J Hepatol; 2005 Mar; 42(3):334-40. PubMed ID: 15710215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy.
    Dammacco F; Sansonno D; Piccoli C; Racanelli V; D'Amore FP; Lauletta G
    Semin Liver Dis; 2000; 20(2):143-57. PubMed ID: 10946420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection.
    Libra M; De Re V; Gloghini A; Callari D; Malaponte G; Travali S; Mazzarino MC; Stivala F; Boiocchi M; Carbone A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):165-70. PubMed ID: 15990705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
    Leroux-Roels G; Esquivel CA; DeLeys R; Stuyver L; Elewaut A; Philippé J; Desombere I; Paradijs J; Maertens G
    Hepatology; 1996 Jan; 23(1):8-16. PubMed ID: 8550052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between hyporesponsiveness to Toll-like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection.
    Chung H; Watanabe T; Kudo M; Chiba T
    J Viral Hepat; 2011 Oct; 18(10):e561-7. PubMed ID: 21914077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland.
    Zucca E; Roggero E; Maggi-Solcà N; Conconi A; Bertoni F; Reilly I; Castelli D; Pedrinis E; Piffaretti JC; Cavalli F
    Haematologica; 2000 Feb; 85(2):147-53. PubMed ID: 10681721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8.
    Hoshida Y; Kato N; Yoshida H; Wang Y; Tanaka M; Goto T; Otsuka M; Taniguchi H; Moriyama M; Imazeki F; Yokosuka O; Kawabe T; Shiratori Y; Omata M
    J Infect Dis; 2005 Jul; 192(2):266-75. PubMed ID: 15962221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma].
    Gasztonyi B; Pár A; Szomor A; Nagy A; Kereskai L; Losonczy H; Pajor L; Horanyi M; Mózsik G
    Orv Hetil; 2000 Dec; 141(49):2649-51. PubMed ID: 11138474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens.
    Simula MP; Caggiari L; Gloghini A; De Re V
    Ann N Y Acad Sci; 2007 Sep; 1110():121-30. PubMed ID: 17911427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women.
    Morton LM; Engels EA; Holford TR; Leaderer B; Zhang Y; Zahm SH; Boyle P; Zhang B; Flynn S; Tallini G; Owens PH; Zheng T
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):425-30. PubMed ID: 15006919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatitis C and immunoglobulin heavy-chain gene rearrangement].
    Gasztonyi B; Pár A; Kereskai L; Pajor L; Kiss K; Szeberényi J; Mózsik G
    Orv Hetil; 2002 Apr; 143(15):767-70. PubMed ID: 11979995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma.
    Yao ZQ; Ni L; Zhang Y; Ma CJ; Zhang CL; Dong ZP; Frazier AD; Wu XY; Thayer P; Borthwick T; Chen XY; Moorman JP
    Immunol Invest; 2011; 40(3):243-64. PubMed ID: 21291295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus and non-Hodgkin's lymphoma 10 years later.
    Mazzaro C; Tirelli U; Pozzato G
    Dig Liver Dis; 2005 Apr; 37(4):219-26. PubMed ID: 15788203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia.
    Ferri S; Dal Pero F; Bortoletto G; Bianchi FB; Lenzi M; Alberti A; Gerotto M
    J Viral Hepat; 2006 Mar; 13(3):166-76. PubMed ID: 16475992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
    Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
    Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.